Ranolazine: Multifaceted role beyond coronary artery disease, a recent perspective

Ranolazine is a piperazine derivative approved as an antianginal. Primarily used as a second-line antianginal in stable coronary artery disease. Ranolazine blocks the late Na + current and prevents the rise of cytosolic calcium. It decreases myocardial wall tension and improves coronary blood flow....

Full description

Bibliographic Details
Main Authors: Gopal Chandra Ghosh, Raktim Kumar Ghosh, Dhrubajyoti Bandyopadhyay, Krishnarpan Chatterjee, Ashish Aneja
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Heart Views
Subjects:
Online Access:http://www.heartviews.org/article.asp?issn=1995-705X;year=2018;volume=19;issue=3;spage=88;epage=98;aulast=Ghosh